Pathological angiogenesis can cause loss of vision and is associated with many diseases of the eye for which there exists no effective treatment. In January 8
Atsushi Otani and colleagues observed that a recombinant fragment of TrpRS is a potent antagonist of vascular endothelial growth factor-induced angiogenesis in a murine model. The effect was also confirmed in naturally occurring retinal angiogenesis in the neonatal mouse (
In a second study Wakasugi